| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 07/27/1994 | EP0576589A4 Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers |
| 07/27/1994 | EP0491713B1 Rubella e1 and c peptides |
| 07/27/1994 | EP0464140B1 Hydrophobic attachment site for adhesion peptides |
| 07/27/1994 | EP0399001B1 T-cell epitope as carriers molecule for conjugate vaccines |
| 07/27/1994 | CN1089950A Derivatives of structurally modified vip and pharmaceutical compositions containing them |
| 07/26/1994 | CA2113979A1 Heterologous signal sequences for secretion of insect controlling proteins |
| 07/26/1994 | CA1331074C Irreversible peptide ligands for bombesin receptors |
| 07/21/1994 | WO1994016091A1 A process for producing immunosuppressives and a novel microbial species to be employed therein |
| 07/21/1994 | WO1994015961A2 Synthetic amphipathic peptides with antimicrobial activity |
| 07/21/1994 | WO1994015959A1 New peptides |
| 07/21/1994 | WO1994015958A2 Peptide inhibitors of cell adhesion |
| 07/21/1994 | WO1994015956A1 Endothelin converting enzyme inhibitors |
| 07/21/1994 | WO1994015637A2 Prevention of suppression of immune defense against cancer caused by the cancer-associated scm-recognition peptides |
| 07/21/1994 | WO1994015587A2 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 07/21/1994 | CA2153228A1 Peptide inhibitors of cell adhesion |
| 07/21/1994 | CA2153051A1 Synthetic amphipathic peptides with antimicrobial activity |
| 07/21/1994 | CA2152380A1 New peptides |
| 07/21/1994 | CA2150574A1 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 07/21/1994 | CA2131623A1 Prevention of suppression of immune defence against cancer caused by the cancer-associated scm-recognition peptides |
| 07/20/1994 | EP0606881A1 Cyclic pentapeptides having a beta-turn and a gamma-turn |
| 07/20/1994 | EP0606804A2 Marker for neurotensin receptor |
| 07/20/1994 | EP0606753A2 Non-reducing saccharide-forming enzyme, and its preparation and uses |
| 07/20/1994 | EP0606481A1 Herbicide containing cyclic hexapeptide as active ingredient |
| 07/20/1994 | EP0606464A1 Peptides capable of controlling acrosome reaction |
| 07/20/1994 | EP0606463A1 Neuromedin b receptor antagonists |
| 07/20/1994 | EP0606222A1 Cyclic hexapeptides as tachyquinin antagonists, their preparation and pharmaceutical compositions thereof |
| 07/20/1994 | EP0484406B1 Polypeptide inhibitor of viral replication |
| 07/20/1994 | EP0366777B1 Stimulation of chemotaxis by chemotactic peptides |
| 07/20/1994 | CN1089660A Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen tyrosinase derived peptides, and methods for......... |
| 07/19/1994 | US5331089 Peptides useful as tachykinin agonists |
| 07/19/1994 | US5330973 Lipopeptide derivatives |
| 07/19/1994 | US5330682 Methods of emulsification with peptide emulsifiers |
| 07/14/1994 | CA2113313A1 Pentapeptide with specific conformaton, its production and use |
| 07/13/1994 | EP0605797A1 Synthetic peptides, antibodies directed against them and their use |
| 07/13/1994 | EP0605627A1 Immunoassay for identifying alcoholics and monitoring alcohol consumption |
| 07/13/1994 | EP0605489A1 Modified peptide derivatives |
| 07/13/1994 | EP0605484A1 Peptides having growth hormone releasing activity |
| 07/13/1994 | EP0605432A1 Induction of cytolytic t-lymphocytes with cytomegalovirus polypeptides |
| 07/13/1994 | EP0497794B1 A microperoxidase preparation containing a hemopeptide as an active component |
| 07/13/1994 | CN1089269A Further novel 5-amino-4-hydroxyhexanoic acid derivatives as therapeutic agents |
| 07/12/1994 | US5328631 Polyaminoacids for heat resistance and biodegradation |
| 07/07/1994 | WO1994014973A1 Novel neutrophil inhibitors |
| 07/07/1994 | WO1994014844A1 Bone resorption assay |
| 07/07/1994 | WO1994014843A1 Endothelin antagonists |
| 07/07/1994 | WO1994014842A1 Difluoro-pentapeptide derivative anti-inflammatory agents |
| 07/07/1994 | WO1994014841A1 Lhrh antagonists having modified aminoacyl residues at postions 5 and 6 |
| 07/07/1994 | WO1994014840A1 Acyclic peptide analogs of the atrial natriuretic peptide, process for producing the same and their use |
| 07/07/1994 | WO1994014839A1 Acyclic, sulphureous peptides as analogs of the atrial natriuretic peptide |
| 07/07/1994 | WO1994014798A1 Aminoacid derivatives of heterocycles as protein kinase c inhibitors |
| 07/07/1994 | WO1994014459A1 Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/tyrosinase peptide antigens |
| 07/07/1994 | WO1994014437A1 Prevention and treatment of sepsis |
| 07/07/1994 | CA2152599A1 Novel neutrophil inhibitors |
| 07/07/1994 | CA2151961A1 Acyclic peptide analogs of the atrial natriuretic peptide, process for producing the same and their use |
| 07/07/1994 | CA2151959A1 Acyclic, sulphureous peptides as analogs of the atrial natriuretic peptide |
| 07/07/1994 | CA2151386A1 Prevention and treatment of sepsis |
| 07/07/1994 | CA2146874A1 Endothelin antagonists |
| 07/07/1994 | CA2136079A1 Lhrh antagonists having modified aminoacyl residues at positions 5 and 6 |
| 07/06/1994 | EP0604957A1 2-Amino-6,7-dihydroxy-4-thiaheptanoic acid derivatives, production and use thereof |
| 07/06/1994 | EP0604945A1 TAN-1511, its derivatives, production and use thereof |
| 07/06/1994 | EP0604552A1 Method of synthesizing diverse collections of oligomers. |
| 07/06/1994 | EP0604488A1 Polypeptides, inhibitors of the replication of hsu and similar viruses |
| 07/06/1994 | EP0604453A1 Disease associated b-cell epitopes of tpo and use thereof |
| 07/06/1994 | EP0579785A4 Substituted benzhydrylamines as handles for solid phase peptide synthesis |
| 07/06/1994 | EP0324788B1 Peptide fragment capable of binding to laminin |
| 07/06/1994 | CN1088935A Hemoregulatory peptides |
| 07/01/1994 | CA2086453A1 Marker for neurotensin receptor |
| 06/29/1994 | EP0603672A2 Process for the production of recombinant and synthetic peptides and their use |
| 06/29/1994 | EP0603399A1 Endothelin-antagonizing peptide |
| 06/29/1994 | EP0603307A1 Monoclonal antibodies to putative hcv e2/ns1 proteins and methods for using same |
| 06/29/1994 | EP0603206A1 Neurotensin method for inhibiting vascular leakage |
| 06/29/1994 | EP0245362B1 Synthetic peptides and use for diagnosis and vaccination for aids and arc |
| 06/29/1994 | CA2112523A1 2-amino-6,7- dihydroxy-4-thiaheptanoic acid derivatives, production and use thereof |
| 06/29/1994 | CA2112522A1 Tan-1511, its derivatives, production and use thereof |
| 06/28/1994 | US5324833 Protected amino acids and process for the preparation thereof |
| 06/28/1994 | US5324716 Microbiocidal oligopeptide for use in human or animal therapy, fungicides, viricides, disinfectants or food preservation |
| 06/28/1994 | US5324708 Non-hygroscopic monoammonium salts of phosphonic and phosphinic acids |
| 06/28/1994 | CA1330420C Compositions containing growth hormone peptide fragments |
| 06/25/1994 | CA2086267A1 Cyclosporin derivatives and derivative conjugates |
| 06/24/1994 | CA2112193A1 Process for preparing recombinant and synthetic peptides, and their use |
| 06/23/1994 | WO1994013795A1 Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications |
| 06/23/1994 | WO1994013698A1 Materials and methods for control of pests |
| 06/23/1994 | WO1994013697A1 Treatment of septic shock with conjugated biologically active peptides |
| 06/23/1994 | WO1994013695A1 Dolostatin analog |
| 06/23/1994 | WO1994013319A1 Cathepsin d is an amyloidogenic protease in alzheimer's disease |
| 06/23/1994 | WO1994013317A1 Sustained-release preparation |
| 06/23/1994 | WO1994013313A1 6-position modified decapeptide lhrh antagonists |
| 06/23/1994 | CA2151953A1 "dolostatin analog" (novel peptides, the preparation and use thereof) |
| 06/23/1994 | CA2151927A1 Cathepsin d is an amyloidogenic protease in alzheimer's disease |
| 06/23/1994 | CA2151046A1 Treatment of septic shock with conjugated biologically active peptides |
| 06/23/1994 | CA2136078A1 6-position modified decapeptide lhrh antagonists |
| 06/22/1994 | EP0602687A1 Modified VP1/P2A regions of rhinovirus systems |
| 06/22/1994 | EP0602237A1 N-acetylglucosaminyltransferase v coding sequences |
| 06/22/1994 | EP0602194A1 Peptide inhibitors of inflammation mediated by selectins |
| 06/22/1994 | EP0602079A1 POLYPEPTIDES CAPABLE OF $i(IN VIVO) INDUCTION OF ANTIBODIES THEMSELVES CAPABLE OF INHIBITING THE INVASION OF RED BLOOD CORPUSCLES BY MEROZOITES OF $i(P.FALCIPARUM), RELATED PRODUCTS AND THEIR USE IN PRODUCING VACCINE COMPOSITIONS |
| 06/22/1994 | EP0602046A1 Detection of feline immunodeficiency viruses |
| 06/22/1994 | EP0545951B1 Hrsv vaccine |
| 06/22/1994 | EP0176588B1 Platelet related growth regulator |
| 06/22/1994 | CN1088216A Modified platelet factor-4 |
| 06/22/1994 | CN1088215A Method for separating bee peptide from bee venom |
| 06/21/1994 | US5322931 Reacting in polar solvent in presence of a dehydrating agent and activating agent |